158 related articles for article (PubMed ID: 25853905)
1. Intraventricular fibrinolysis with tissue plasminogen activator is associated with transient cerebrospinal fluid inflammation: a randomized controlled trial.
Kramer AH; Jenne CN; Zygun DA; Roberts DJ; Hill MD; Holodinsky JK; Todd S; Kubes P; Wong JH
J Cereb Blood Flow Metab; 2015 Aug; 35(8):1241-8. PubMed ID: 25853905
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Pharmacodynamics of Tissue Plasminogen Activator Administered Through an External Ventricular Drain.
Kramer AH; Jenne C; Holodinsky JK; Todd S; Roberts DJ; Kubes P; Zygun DA; Hill MD; Leger C; Wong JH
Neurocrit Care; 2015 Dec; 23(3):386-93. PubMed ID: 25739904
[TBL] [Abstract][Full Text] [Related]
3. Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis.
Gaberel T; Montagne A; Lesept F; Gauberti M; Lemarchand E; Orset C; Goulay R; Bertrand T; Emery E; Vivien D
Neuropharmacology; 2014 Oct; 85():158-65. PubMed ID: 24846802
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A randomized trial and individual patient data meta-analysis.
Staykov D; Kuramatsu JB; Bardutzky J; Volbers B; Gerner ST; Kloska SP; Doerfler A; Schwab S; Huttner HB
Ann Neurol; 2017 Jan; 81(1):93-103. PubMed ID: 27888608
[TBL] [Abstract][Full Text] [Related]
5. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial.
Kramer AH; Roberts DJ; Holodinsky J; Todd S; Hill MD; Zygun DA; Faris P; Wong JH
Neurocrit Care; 2014 Oct; 21(2):275-84. PubMed ID: 24627207
[TBL] [Abstract][Full Text] [Related]
6. No exacerbation of perihematomal edema with intraventricular tissue plasminogen activator in patients with spontaneous intraventricular hemorrhage.
Ziai W; Moullaali T; Nekoovaght-Tak S; Ullman N; Brooks JS; Morgan TC; Hanley DF
Neurocrit Care; 2013 Jun; 18(3):354-61. PubMed ID: 23463422
[TBL] [Abstract][Full Text] [Related]
7. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis using urokinase in severe ventricular haemorrhage.
Du B; Wang J; Zhong XL; Liang J; Xiang W; Chen D; Lv W; Shan AJ
Brain Inj; 2014; 28(11):1413-6. PubMed ID: 24830742
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous Intraventricular Hemorrhage: When Should Intraventricular tPA Be Considered?
Abdelmalik PA; Ziai WC
Semin Respir Crit Care Med; 2017 Dec; 38(6):745-759. PubMed ID: 29262432
[TBL] [Abstract][Full Text] [Related]
9. Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment.
Mayfrank L; Kissler J; Raoofi R; Delsing P; Weis J; Küker W; Gilsbach JM
Stroke; 1997 Jan; 28(1):141-8. PubMed ID: 8996503
[TBL] [Abstract][Full Text] [Related]
10. Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator.
Mayfrank L; Kim Y; Kissler J; Delsing P; Gilsbach JM; Schröder JM; Weis J
Acta Neuropathol; 2000 Nov; 100(5):561-7. PubMed ID: 11045679
[TBL] [Abstract][Full Text] [Related]
11. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose-effect relationship.
Wang YC; Lin CW; Shen CC; Lai SC; Kuo JS
J Neurol Sci; 2002 Oct; 202(1-2):35-41. PubMed ID: 12220690
[TBL] [Abstract][Full Text] [Related]
13. Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.
Murthy SB; Awad I; Harnof S; Aldrich F; Harrigan M; Jallo J; Caron JL; Huang J; Camarata P; Lara LR; Dlugash R; McBee N; Eslami V; Hanley DF; Ziai WC;
Neurology; 2017 Jul; 89(4):355-362. PubMed ID: 28659429
[TBL] [Abstract][Full Text] [Related]
14. Intraventricular streptokinase increases cerebrospinal fluid D dimer in preterm infants with posthaemorrhagic ventricular dilatation.
Whitelaw A; Mowinckel MC; Larsen ML; Røkås E; Abildgaard U
Acta Paediatr; 1994 Mar; 83(3):270-2. PubMed ID: 8038528
[TBL] [Abstract][Full Text] [Related]
15. Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator.
Varelas PN; Rickert KL; Cusick J; Hacein-Bey L; Sinson G; Torbey M; Spanaki M; Gennarelli TA
Neurosurgery; 2005 Feb; 56(2):205-13; discussion 205-13. PubMed ID: 15670368
[TBL] [Abstract][Full Text] [Related]
16. Lower dose intraventricular T-PA fibrinolysis: case report.
Deutsch H; Rodriguez JC; Titton RL
Surg Neurol; 2004 May; 61(5):460-3; discussion 463. PubMed ID: 15120223
[TBL] [Abstract][Full Text] [Related]
17. Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?
Whitelaw A; Mowinckel MC; Abildgaard U
Acta Paediatr; 1995 Aug; 84(8):933-6. PubMed ID: 7488820
[TBL] [Abstract][Full Text] [Related]
18. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.
Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; Narula R; Guo KH; Claassen J; Lee K; Badjatia N; Mayer SA; Connolly ES
Neurosurgery; 2010 Apr; 66(4):648-55. PubMed ID: 20305489
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage.
Etminan N; Beseoglu K; Eicker SO; Turowski B; Steiger HJ; Hänggi D
Stroke; 2013 Aug; 44(8):2162-8. PubMed ID: 23735957
[TBL] [Abstract][Full Text] [Related]
20. [Thrombolytic therapy after intraventricular haemorrhage].
Gadegaard KH; Dahl BL; Hansen TS
Ugeskr Laeger; 2010 May; 172(19):1440-1. PubMed ID: 20470653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
